Updated:
Biofourmis Inc.
Biofourmis merged with CopilotIQ to deliver AI-driven in-home care for more than 50 health systems, cutting readmissions by 70%.
Biofourmis Inc.
Biofourmis was launched in 2015 with a mission to extend clinical-grade care into the home using a connected technology platform. Headquartered in Boston and operating additional offices in Singapore and India, the company partners with risk-bearing organizations and life science companies to shift care delivery out of hospitals and into residential settings. Biofourmis deploys a proprietary AI engine across a care continuum that spans remote patient monitoring, acute care-at-home programs, and drug-lifecycle management for pharmaceutical partners. Following its merger with CopilotIQ, the combined entity positions itself as an end-to-end in-home care platform. The client base exceeds 50 health systems and payers, including named relationships with AdventHealth and Lee Health. Geographic delivery spans the United States and select international markets, with an India office supporting scaling operations. In recent months, the firm sold its life-science division to ActiGraph, a transaction that sharpens Biofourmis's focus on direct clinical-care delivery rather than drug-trial enablement. The company publicly reports clinical outcomes including a 70% reduction in 30-day hospital readmissions and a 38% reduction in cost of care from a 2020 randomized controlled trial published in the Annals of Internal Medicine. The structural differentiator is the company's post-merger architecture: by combining CopilotIQ's chronic-condition management with Biofourmis's acute-care platform, the new entity controls both ends of the in-home care spectrum. This makes it one of the few technology-native operators simultaneously managing patient panels for hospital systems, payers, and the pharmaceutical industry.
General information
Firm type
Asset Manager
Year founded
2015
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Additional offices
Singapore · India
Sector focus
Frequently asked questions
How does Biofourmis deliver care at home?
Biofourmis uses a connected technology platform that combines wearable biosensors with machine learning to monitor patients remotely. The system detects clinical deterioration early — the company claims up to 21 hours sooner than conventional monitoring — and supports transitions between hospital-level acute care and lower-acuity home settings.
What clinical outcomes has Biofourmis reported?
The firm cites a 70% reduction in 30-day hospital readmissions and up to a 38% reduction in cost of care, drawing on a 2020 randomized controlled trial published in the Annals of Internal Medicine (Levine et al., 2020) and a 2021 observational study in Scientific Reports (Un et al., 2021).
Is Biofourmis a single-family office or a technology company?
Biofourmis is a technology and healthcare-services company, not a family office. It operates as a venture-backed enterprise focused on AI-driven care delivery for health systems, payers, and life-science organizations.
How is Biofourmis related to CopilotIQ?
Biofourmis and CopilotIQ merged to form a single end-to-end platform for AI-driven in-home care. The combination brings Biofourmis's acute-care remote monitoring together with CopilotIQ's chronic-condition management capabilities.
Which large health systems has Biofourmis partnered with?
Biofourmis's website names AdventHealth and Lee Health as collaborators. AdventHealth supports a 'whole person care' acute care-at-home program, while Lee Health is expanding remote patient monitoring and home-based hospital care services.
Does Biofourmis still serve life-science customers?
Biofourmis sold its life-science division to ActiGraph in late 2023, a move that narrowed the company's focus to clinical care delivery. The firm no longer runs clinical-trial or drug-companion programs in-house.
Where are Biofourmis's global offices located?
Biofourmis maintains a headquarters in Boston, Massachusetts, and offices in Singapore and India. The Singapore office anchors its Asia-Pacific presence, while the India location supports operational and technology scaling.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: